Cell line designation change: Multidrug-resistant cell line in the NCI anticancer screen

被引：85

作者：

Scudiero, DA

Monks, A

Sausville, EA

机构：

[1] NCI, Frederick Canc Res & Dev Ctr, Sci Applicat Int Corp, Frederick, MD 21702 USA

[2] NCI, Dev Therapeut Program, Div Canc Treatment Diag & Ctr, Bethesda, MD 20892 USA

来源：

JOURNAL OF THE NATIONAL CANCER INSTITUTE | 1998年 / 90卷 / 11期

关键词：

D O I：

10.1093/jnci/90.11.862

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：862 / 862

页数：1

共 5 条

[1] GENERATION OF A DRUG-RESISTANCE PROFILE BY QUANTITATION OF MDR-1/P-GLYCOPROTEIN IN THE CELL-LINES OF THE NATIONAL-CANCER-INSTITUTE ANTICANCER DRUG SCREEN [J].

ALVAREZ, M ;

PAULL, K ;

MONKS, A ;

HOSE, C ;

LEE, JS ;

WEINSTEIN, J ;

GREVER, M ;

BATES, S ;

FOJO, T .

JOURNAL OF CLINICAL INVESTIGATION, 1995, 95 (05) :2205-2214

[2]

LEE JS, 1994, MOL PHARMACOL, V46, P627

[3] FEASIBILITY OF A HIGH-FLUX ANTICANCER DRUG SCREEN USING A DIVERSE PANEL OF CULTURED HUMAN TUMOR-CELL LINES [J].

MONKS, A ;

SCUDIERO, D ;

SKEHAN, P ;

SHOEMAKER, R ;

PAULL, K ;

VISTICA, D ;

HOSE, C ;

LANGLEY, J ;

CRONISE, P ;

VAIGROWOLFF, A ;

GRAYGOODRICH, M ;

CAMPBELL, H ;

MAYO, J ;

BOYD, M .

JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1991, 83 (11) :757-766

[4]

STINSON SF, 1992, ANTICANCER RES, V12, P1035

[5]

WU L, 1992, CANCER RES, V52, P3029

← 1 →